Showing results (551-560 of 604) with videos related to

Sort By:
Pageof 61
Clinical and Experimental Rheumatology|March 29, 2022
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaisonChiara Baldini, Laurent Arnaud, Tadej Avčin, et al.
The Journal of Rheumatology|December 3, 2019
Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 PatientsRaphael Lhote, Marie Chilles, Matthieu Groh, et al.
Annals of the Rheumatic Diseases|January 18, 2026
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)Liubov Petelytska, Lorenzo Tofani, Arthiha Velauthapillai, et al.
Annals of the Rheumatic Diseases|August 17, 2012
TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patientsEugénie Koumakis, Julien Wipff, Philippe Dieudé, et al.
Annals of the Rheumatic Diseases|November 2, 2023
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trialsFlorence Delestre, Pierre Charles, Alexandre Karras, et al.
Plos Genetics|July 14, 2011
Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosisYannick Allanore, Mohamad Saad, Philippe Dieudé, et al.
The Journal of Allergy and Clinical Immunology|August 16, 2024
Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosisGuillaume Lefèvre, Jean-Baptiste Gibier, Antonino Bongiovanni, et al.
Clinical & Translational Immunology|December 30, 2020
Severe SARS-CoV-2 patients develop a higher specific T-cell responseJulie Demaret, Guillaume Lefèvre, Fanny Vuotto, et al.
Annals of the Rheumatic Diseases|November 19, 2020
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trialRenaud Felten, Valérie Devauchelle-Pensec, Raphaèle Seror, et al.
Annals of the Rheumatic Diseases|September 2, 2015
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, David Launay, Rennie L Rhee, et al.
Pageof 61